Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina.
about
Anatomical effects of dexamethasone intravitreal implant in diabetic macular oedema: a pooled analysis of 3-year phase III trialsUpdates on the Clinical Trials in Diabetic Macular EdemaSteroids in Central Retinal Vein Occlusion: Is There a Role in Current Treatment Practice?Role of implants in the treatment of diabetic macular edema: focus on the dexamethasone intravitreal implantThe role of aflibercept in the management of diabetic macular edemaDexamethasone intravitreal implant in the treatment of diabetic macular edemaThe multifactorial nature of retinal vascular diseaseDiabetic macular edema: new concepts in patho-physiology and treatment.Upcoming therapeutic advances in diabetic macular edema: an intravitreal dexamethasone drug delivery system.Adult coats' disease successfully managed with the dexamethasone intravitreal implant (ozurdex®) combined with retinal photocoagulation.Usefulness of the vitreous fluid analysis in the translational research of diabetic retinopathyPathophysiology and treatment of diabetic retinopathy.Correlation between decreased choroidal blood flow velocity and the pathogenesis of acute zonal occult outer retinopathy.Steroid differentiation: the safety profile of various steroids on retinal cells in vitro and their implications for clinical use (an American Ophthalmological Society thesis).Antagonism of CD11b with neutrophil inhibitory factor (NIF) inhibits vascular lesions in diabetic retinopathy.Efficacy and safety of different doses of a slow-release corticosteroid implant for macular edema: meta-analysis of randomized controlled trialsDexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD study.Morphology and Function over a One-Year Follow Up Period after Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema.Decrease in retinal neuronal cells in streptozotocin-induced diabetic mice.Progression of Diabetic Capillary Occlusion: A Model.Evidence-Based Treatment of Diabetic Macular Edema.Clinical utility of intravitreal fluocinolone acetonide (Iluvien®) implant in the management of patients with chronic diabetic macular edema: a review of the current literatureIntravitreal Injection of Ozurdex(®) Implant in Patients with Persistent Diabetic Macular Edema, with Six-Month Follow-Up.Effect of intravitreal dexamethasone implant on retinal and choroidal thickness in refractory diabetic macular oedema after multiple anti-VEGF injections.Vascular adhesion protein 1 in the eye.Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy.Inflammatory biomarkers and progression of diabetic retinopathy in African Americans with type 1 diabetes.Intravitreal triamcinolone acetonide: Pattern of secondary intraocular pressure rise and possible risk factors.Cytoplasmic translocation of high-mobility group box-1 protein is induced by diabetes and high glucose in retinal pericytesTreatment of polypoidal choroidal vasculopathy by photodynamic therapy, aflibercept and dexamethasone triple therapy.Ruboxistaurin: PKC-beta inhibition for complications of diabetes.Anti-inflammatory therapy for diabetic retinopathy.Fluocinolone acetonide for the treatment of diabetic macular edema.Coat's-like exudation in rhodopsin retinitis pigmentosa: successful treatment with an intravitreal dexamethasone implantAn eighteen-month follow-up study on the effects of Intravitreal Dexamethasone Implant in diabetic macular edema refractory to anti-VEGF therapy.Intravitreal triamcinolone acetonide inhibits breakdown of the blood-retinal barrier through differential regulation of VEGF-A and its receptors in early diabetic rat retinas.Novel pentablock copolymer (PLA-PCL-PEG-PCL-PLA) based nanoparticles for controlled drug delivery: Effect of copolymer compositions on the crystallinity of copolymers and in vitro drug release profile from nanoparticles.Panretinal Photocoagulation Using Short-Pulse Laser Induces Less Inflammation and Macular Thickening in Patients with Diabetic RetinopathyFluocinolone acetonide and its potential in the treatment of chronic diabetic macular edema.Combined Intravitreal Dexamethasone Implant And Micropulse Yellow Laser For Treatment Of Anti-VEGF Resistant Diabetic Macular Edema.
P2860
Q24658545-0CAB20F2-7455-408A-AE77-D8B38E00A41DQ26767100-2D7E9174-4A4B-4F28-AA96-CFAAB88599B1Q26774524-36EC9AA6-0A56-495F-9F70-F9A2E8C10DAEQ26775853-63403732-78EB-4AB8-9B93-44998C594870Q26798348-AA6B801E-D10A-4FE5-AAE9-37BE695A682FQ26799423-1EDF29DF-9F66-4B12-8232-D105EFE8ECBAQ33660130-03C42B1B-8D45-4FDA-9628-0ED35A9A463CQ33713517-D749FC86-C158-45E2-BB43-5826B8DC9ED9Q33790255-BCB94D78-11A0-42E3-A0CD-B719B82BC985Q34252617-AB1F0893-3D7E-4758-99E3-F1FD2A8EA77EQ34426246-5DE249BB-6CE1-4165-B0B9-72EABB0080C5Q34528134-CC8283F8-C456-4CAF-81E9-74B1CB5704C0Q34777421-75F2FDA2-40DD-49CC-85D4-17ECF79ECB0FQ35030923-A907AC46-C2CE-4BAA-926F-0D073BC4542FQ35036412-F815C6DB-79F6-449C-A11D-FFD2ED3C9AFFQ35594036-419A0B3D-D159-41E8-89D1-DAB662F34CF5Q35828114-00FABC59-6C15-4E7E-AEE5-B2512E953F06Q35882571-99DC2858-9B96-423A-B81E-2A31C25DB64EQ36015795-95D92A53-4B02-42E9-9B54-B82952EE4023Q36051940-429622B3-D179-4A3E-8890-1086D92AC44DQ36242390-91A70F17-A557-4E34-BC71-D97AE782E4E3Q36341458-EAAC8E20-70F5-4D49-8B82-DD5AB780DE49Q36856905-5C043E46-E740-47A4-B232-413C04281DB9Q36906893-4B5880F7-66A2-440C-9633-E6D06B848375Q36942812-E4D51BBC-2E3A-4C9D-90D6-54E144F66331Q37084522-EE80097B-30C4-42D3-BEB7-15CF4BB8BB26Q37095335-8E34592E-D43C-47CB-99BB-3F028EEABE2FQ37221486-B4CDA87A-099B-485C-8A02-C1BBF08706BFQ37297418-2469CAA0-A968-458B-91A7-C89BB0BF917AQ37416874-67D103AE-42D5-4B31-8E49-06DF2E8F74F6Q37636163-256B4B9A-89C8-4372-AEF5-7FE32F37351FQ37873482-0B26F061-5ED7-4613-8265-4E72DF66EC4FQ38648612-1C35CBCD-8F2C-44A9-A984-09AF1A8A6174Q38709587-D82C683F-3A4F-4CBB-8814-9FBA4FEFBEFFQ39225517-F5BE0CF4-7C78-48FF-B1CE-8CA3BE8AB65CQ39545613-A56DAA83-BD34-4DAB-8461-22D81E753B25Q40010634-74623E3F-E9CA-48E9-B5CF-33FBA556E9B7Q41067724-B41B9375-6D38-41A5-9383-88791772CCD0Q41236033-77C6F6E9-19ED-45DE-B82F-1A5BBF64C949Q41250047-606977FA-0C98-43A5-8CAE-B72299F78854
P2860
Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Intravitreal injection of cort ...... experimental diabetic retina.
@en
Intravitreal injection of cort ...... experimental diabetic retina.
@nl
type
label
Intravitreal injection of cort ...... experimental diabetic retina.
@en
Intravitreal injection of cort ...... experimental diabetic retina.
@nl
prefLabel
Intravitreal injection of cort ...... experimental diabetic retina.
@en
Intravitreal injection of cort ...... experimental diabetic retina.
@nl
P2093
P356
P1476
Intravitreal injection of cort ...... experimental diabetic retina.
@en
P2093
Fumitaka Hirose
Hideto Katsuta
Hiroshi Tamura
Junichi Kiryu
Kazuaki Miyamoto
Kunihiro Musashi
Shinsuke Miyahara
P304
P356
10.1167/IOVS.04-0905
P407
P577
2005-04-01T00:00:00Z